Appraisal in progress
Indication |
|
| Status: In progress | |
Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults. |
|
Medicine details |
|
| Medicine name | hydrocortisone MR (Efmody®) |
| Formulation | 5 mg, 10 mg, 20 mg modified-release hard capsules |
| Reference number | 3017 |
| Indication | As above |
| Company | Diurnal Limited |
| BNF chapter | Endocrine system |
| Submission type | Full |
| Status | In progress |
| NMG meeting date | 06/07/2022 |
| AWMSG meeting date | 14/09/2022 |
| Date of issue | TBC |